Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Neuroendocrine neoplasia (NENs) are heterogeneous tumours caracterized by a relatively indolent rate of growth. Usually, in G1 and G2 GEP-NENs, first-line therapy is SSAs, considering their efficacy, good safety profile, and antiproliferative effects. SSA treatment inhibits the production and excretion of pancreatic enzymes and PEI is known to be an adverse effect of SSA treatment.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Rinzivillo M
Authors: De Felice I, Rinzivillo M, Pratesi M, Magi L, Annibale B,
Keywords: Pancreatic Exocrine Insufficiency,
Introduction: Long acting somatostatin analogues (SSA) are the most commonly used drugs in the management of neuroendocrine tumours (NETs) due to their ability to control symptoms and prolong survival. SSAs use is associated with changes in glucose metabolism. However, there is lack of data for such effects in patients with NETs. We evaluated the effects of SSA on BMI and HbA1c in our cohort of patients with NETs.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Patel K
Authors: Patel K, Nahar A, Elhassan Y, Shah T, Ayuk J,
Keywords: Somatostatin analogues, Diabetes, Neuroendocrine tumour, HbA1c, BMI,
Introduction: There is previous data demonstrating that elevated gastrin levels could exert some effect potentiating the glucose-induced insulin secretion.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Mavroeidi V
Authors: Moschouris P, Mavroeidi V, Nikolopoulos G, Tsoli M, Karapanagioti A,
Keywords: Gastric Neuroendocrine Tumors Type 1, ECL-Cells Hyperplasia, gastrin, glucose,
#1145 The Association Between Gastrin and Glucose Serum Concentration
Introduction: Gastrin is an early incretin candidate, since it is released by oral glucose and potentiates the glucose- induced insulin secretion. It has been shown that only in hypoglycemic or hyperglycemic conditions gastrin release is influenced by changes in blood glucose and insulin concentrations.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Boutzios G
Authors: Boutzios G, Alexandraki K, Moschouris P, Chatzellis E, Evaggelatou A,
Keywords: gastrin levels, glucose levels, HbA1c,
#904 Role of Metformin on Recurrence-Free Survival (RFS) in Neuroendocrine Tumors (NET)
Introduction: Recent data suggest metformin (Met) has antineoplastic properties in different type of cancer. Effects of Met have never been investigated in NET.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Marciello F
Authors: Marciello F, Del Prete M, Marotta V, Ramundo V, Buonomano P,